The FDA's lax oversight of research in developing countries can do harm to vulnerable participants
Regulatory loopholes for research conducted off US soil allow for questionable trials and misleading data to slip under the FDA’s radar.
C. Michael White, Distinguished Professor and Head of the Department of Pharmacy Practice, University of Connecticut •
conversation
Nov. 12, 2021 • ~5 min
Nov. 12, 2021 • ~5 min